Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Lay abstracts

Lay abstracts A Pharmacogenetic Study of Escitalopram in Autism Spectrum Disorders Thomas Owley, Camille W. Brune, Jeff Salt, Laura Walton, Steve Guter, Nelson Ayuyao, Robert D. Gibbons, Bennett L. Leventhal, and Edwin H. Cook LAY ABSTRACT Many children with Autism Spectrum Disorders have problems with anxiety, obsessions, compulsions, and insisting that things stay the same. When other interventions are not adequately helping the child deal with these difficulties, sometimes medication is considered a treatment option. Serotonin is inactivated when it is taken back into nerve cells by a protein called the serotonin transporter. Escitalopram blocks this protein. We wanted to know if variation in the gene that produces the protein target for escitalopram would be related to response to this treatment. © 2010 INSAR / Wiley Periodicals, Inc. Article Citation: Autism Res 2010, 3: 1–7 . DOI: 10.1002/aur.109 MEG Detection of Delayed Auditory Evoked Responses in Autism Spectrum Disorders: Towards an Imaging Biomarker for Autism Timothy P.L. Roberts, Sarah Y. Khan, Mike Rey, Justin F. Monroe, Katelyn Cannon, Lisa Blaskey, Sarah Woldoff, Saba Qasmieh, Mike Gandal, Gwen L. Schmidt, Deborah M. Zarnow, Susan E. Levy, and J. Christopher Edgar LAY ABSTRACT Auditory and speech problems are frequently observed in individuals http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Autism Research Wiley

Lay abstracts

Autism Research , Volume 3 (1) – Feb 1, 2010

Loading next page...
 
/lp/wiley/lay-abstracts-M3y2eB0J3y

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Wiley
Copyright
Copyright © 2010, International Society for Autism Research, Wiley Periodicals, Inc.
ISSN
1939-3792
eISSN
1939-3806
DOI
10.1002/aur.117
Publisher site
See Article on Publisher Site

Abstract

A Pharmacogenetic Study of Escitalopram in Autism Spectrum Disorders Thomas Owley, Camille W. Brune, Jeff Salt, Laura Walton, Steve Guter, Nelson Ayuyao, Robert D. Gibbons, Bennett L. Leventhal, and Edwin H. Cook LAY ABSTRACT Many children with Autism Spectrum Disorders have problems with anxiety, obsessions, compulsions, and insisting that things stay the same. When other interventions are not adequately helping the child deal with these difficulties, sometimes medication is considered a treatment option. Serotonin is inactivated when it is taken back into nerve cells by a protein called the serotonin transporter. Escitalopram blocks this protein. We wanted to know if variation in the gene that produces the protein target for escitalopram would be related to response to this treatment. © 2010 INSAR / Wiley Periodicals, Inc. Article Citation: Autism Res 2010, 3: 1–7 . DOI: 10.1002/aur.109 MEG Detection of Delayed Auditory Evoked Responses in Autism Spectrum Disorders: Towards an Imaging Biomarker for Autism Timothy P.L. Roberts, Sarah Y. Khan, Mike Rey, Justin F. Monroe, Katelyn Cannon, Lisa Blaskey, Sarah Woldoff, Saba Qasmieh, Mike Gandal, Gwen L. Schmidt, Deborah M. Zarnow, Susan E. Levy, and J. Christopher Edgar LAY ABSTRACT Auditory and speech problems are frequently observed in individuals

Journal

Autism ResearchWiley

Published: Feb 1, 2010

There are no references for this article.